SRSF12是一种预后生物标志物,参与急性髓性白血病的免疫透

MengMeng Zhang1, YuanYuan Tan1, ZhiBin Xie1

  • 1Department of Hematology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233003, Anhui Province, People's Republic of China.

概括

在急性髓性白血病 (AML) 患者中,高SRSF12表达表明预后不佳. 这一发现可能为AML提供新的诊断和向治疗选择.